Navigation Links
EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
Date:5/13/2008

ROCKVILLE, Md., May 13 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer, will present a Company overview at the Rodman and Renshaw 5th Annual Global Healthcare Conference, to be held at the Le Meridien Beach Plaza Hotel in Monte Carlo, May 19-20, 2008. Mr. Burns' presentation is scheduled for Monday, May 19, 2008 at 10:25 a.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

As previously mentioned, Mr. Burns' live presentation will be web cast and will serve as the Company's first quarter 2008 update. The presentation can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. ENMD-1198, a novel antimitotic agent, and ENMD-2076, a selective kinase inhibitor, are in Phase 1 studies in advanced cancers. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation - processes vital to the treatm
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. EntreMed Reports First Quarter 2008 Financial Results
2. Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
3. EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference
4. EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
5. EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
6. EntreMed Reports Third Quarter 2007 Financial Results
7. EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
8. EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
9. EntreMed to Present at the Bio 2007 Investor Forum
10. EntreMed Receives Deloitte Technology Fast 50 Award
11. Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Medical Products Inc., an industry leader in healt...nounces the opening of its new headquarters in the...247 Research Drive, Irvine, California 92618. In a...in the Irvine Spectrum plus an assembly and distri...ecent expansion reflects Links Medical,s rapid gro...
(Date:12/2/2009)...law firm prevails in counterclaim against three pl...art of business dispute over work done on hotel co...pa, Fla. (Lexis Nexis) December 2, 2009 -- The Tam...ntly completed the settlement of a two-year legal ...firm,s client, ConArt, Inc., , ,ConArt, a Georgia-...
(Date:12/2/2009)...f., Dec. 1 Last month on a promine...layo, Associate Professor at the Stanford Sleep Di...dicine, recommended the Ecotones Duet Sleep Sound ... trying to achieve a better night,s sleep with min...oblem for people when they are sleeping," said Dr....
(Date:12/2/2009)...ewswire-USNewswire/ -- Targeted breast ultrasound ..., is a safe, reliable and cost-effective alternati...cording to the findings of two studies presented t...iety of North America (RSNA). ,, "By performing... number of expensive and avoidable invasive diagno...
(Date:12/2/2009)...led study comparing standard conservative therapy ...ous disc decompression for painful herniated disc ...in the short run, only disc decompression kept pat...the study, the first of its kind, were presented t...iety of North America (RSNA). , Discs are sponge...
Breaking Medicine News(10 mins):Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Gallagher Keenan Obtains $500,000 Settlement for ConArt, Inc. in Dispute with Florida Hotel Companies 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:Outpatient disc treatment gives long-term back pain relief 2
...and six other Northeastern states in the US are st...nment to enact tougher standards of mercury emissi...amination has become a growing health concern. Mer...ssions drift across state borders, and the mercury...
... to the annual report of UK’S National Institute o... lowest ever, there are also definite steps // bei...tion are reduced by 20 percent, within the next th... of treatment. Another problem area identified is ...
...ice and home guard personnel will guard the Lok Na... curb the alleged manhandling of doctors/ by relat...curity firm taking care of the hospital has been r...Negi told IANS. Since Wednesday, 700 reside...
...majority" of elderly people will soon be living in...n 25 years, a UN agency says citing// India and Ch...phenomenon of a rapidly ageing population can no l...tions are in transition as well," Somnath Chatterj...
...e have died from encephalitis disease in western B...s, which has created panic among people// as the n...ushtia General Hospital said that more than 50 peo...tal and Civil Surgeon's office, the disease first ...
...gears up to implement the third phase of its Natio...districts will be made implementing// authorities ... The goal is to "to halt and reverse the epid... All districts are scheduled to become power...
Other Medicine News:Health News:US States Get Ready to Fight Mercury Pollution 2Health News:India to Hike Free Treatments in Fight Against AIDS 2
(Date:12/1/2009)...E, Wash., Dec. 1 drugsto...tailer of health, beauty, vision, and pharmacy pro...est day ever as customer orders were the highest i...ore.com and Beauty.com web stores featured more...argest gift selection yet. ,, (Logo: http://ww...
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Latin American Pharmaceu...market analysis, forecasts and growth opportunitie...atin-American-Pharmaceutical-Market-Outlook-To-201...-growth-opportunities.html ,, The $28.8bn La...
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Contract Research Outsourc... Opportunities ,, http://www.reportlinker.com...obal-Update-of-Market-Trends--Opportunities.html ...ame into being in the seventies, evolved into an e...
Breaking Medicine Technology:drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 8Investing wisely to save the Great Barrier Reef 9116 1Investing wisely to save the Great Barrier Reef 9116 2Canadian researchers set to study impact of nanomaterials on aquatic ecosystems 9112 1Canadian researchers set to study impact of nanomaterials on aquatic ecosystems 9112 2Who Says Negatives Cant Be Positive 3F 50764 1Who Says Negatives Cant Be Positive 3F 50764 2Who Says Negatives Cant Be Positive 3F 50764 3
...st inclusion of Volcano Revolution(R) 45 MHz IVUS,...laque progression trial., SAN DIEGO, May 5 Volca...rer and developer of intravascular ultrasound,(IVU...nce Tomography (OCT),products designed to enhance ...eral vascular disease, announced today participati...
... Quick, Effective Analgesia for Peripheral Venous ...rs of Age -(1), SOUTH SAN FRANCISCO, Calif., May ...he publication of data in Pediatrics,the journal o... 3 trial of,Zingo(TM) (lidocaine hydrochloride mon...y,s fast-acting, topical, needle-free local,anesth...
Other Medicine Technology:Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 3Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics 2Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics 3Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics 4Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics 5
IEC FL40R Centrifuges
IEC CL30R Centrifuge
Automatic Blood Pressure Monitor
Neonatal Secure ID Bands
Medicine Products: